The Nightdive Studios port of Turok is now better than ever, as the team drops a surprise update that overhauls the entire ...
18h
GlobalData on MSNBambusa Therapeutics doses first volunteers in Phase I bispecific AD trialThe Phase I trial will recruit approximately 98 healthy volunteers and adults living with atopic dermatitis at a single site ...
This’ll be our eighth year.” Our, being Sirianni and Kevin Patullo. Year, being yet another offseason cycle together. Fitting ...
A PS2 series that got its starts in 2004 looks poised to return with a new release, according to a new Bandai Namco leak.
8h
SB Nation on MSNSmackDown live blog: Elimination Chamber go homeFollow along with this week’s episode, the last stop before the Elimination Chamber PLE. Cody Rhodes speaks, and more!
Tryn Stimart; Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer; Abcellera Biologics Inc. Carl L. Hansen; CEO, President & Chairper ...
In the early 1960s, the Institute grappled with going beyond “Duck and Cover.” The bombing of Hiroshima and Nagasaki in ...
It is a sandwich with the rarest of fillings. Researchers have unveiled berkelocene, a compound containing the synthetic element berkelium nestled neatly between two ring-shaped molecules (Science ...
The FDA approved the investigational new drug application for a phase 1 trial of ADCE-T02 in advanced solid tumors.
Lazarus, the latest anime from the creator of Cowboy Bebop and Samurai Champloo, has a release date, and it's pretty soon.
Nordic Pharma, Inc., a subsidiary of Nordic Group B.V., announced today a poster presentation at SECO 2025 being held from February 26 ? March 2 in Atlanta, Georgia. Mile Brujic, OD, FAAO of Premier ...
Eli Lilly and Company will participate in Leerink Partners Global Healthcare Conference on March 10, 2025. Lucas Montarce, Lilly executive vice president and chief financial officer, will take part in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results